High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines

Clinical Endocrinology

Volumn 61, Issue 6, 2004, Pages 768-777

  Mancini, Tatiana ^a   Kola, Blerina ^a   Mantero, Franco ^b   Boscaro, Marco ^a   Arnaldi, Giorgio ^a,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; DEXAMETHASONE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN; TRIACYLGLYCEROL; URIC ACID;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERCORTISOLISM; HYPERLIPIDEMIA; HYPERTENSION; HYPOPHYSIS ADENOMA; MALE; METABOLIC DISORDER; MORTALITY; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

ADULT; CARDIOVASCULAR DISEASES; CUSHING SYNDROME; DIABETES MELLITUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; RISK; TIME FACTORS;

EID: 10844237159     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02168.x     Document Type: Article

References (39)

1. Alberti, K.G. & Zimmet, P.Z. (1998) WHO consultation, definition, diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine, 15, 539.
2. Andrews, R.C. & Walker, B.R. (1999) Glucocorticoids and insulin resistance: old hormones, new targets. Clinical Science, 96, 513-523.
3. Arnaldi, G., Angeli, A., Atkinson, A.B., Bertagna, X., Cavagnini, F., Chrousos, G., Fava, G.A., Findling, J., Gaillard, R.C., Grossman, A.B., Kola, B., Lacroix, A., Mancini, T., Mantero, F., Newell-Price, J., Nieman, L.K., Sonino, N., Vance, M.L., Giustina, A. & Boscaro, M. (2003a) Diagnosis and complications of Cushing's syndrome: a Consensus Statement. Journal of Clinical Endocrinology and Metabolism, 88, 5593-5602,
4. Arnaldi, G., Mancini, T., Kola, B., Appolloni, G., Freddi, G., Concettoni, C., Bearzi, I., Masini, A., Boscaro, M. & Mantero, F. (2003b) Cyclical Cushing's syndrome in a patient with bronchial neuroendocrine tumour (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. Journal of Clinical Endocrinology and Metabolism, 88, 5834-5840.
5. Biering, H., Knappe, G., Gerl, H. & Lochs, H. (2000) Prevalence of diabetes in acromegaly and Gushing syndrome. Acta Medico Austriaca, 27, 27-31.
6. Biglieri, E.G., Kater, C.E. & Mantero, F. (1995) Adrenocortical forms of human hypertension. In: Hypertension: Pathophysiology, Diagnosis and Management (eds J.H. Laragh & B.M. Brenner), 2nd edn, pp. 2145-2162. Raven Press, New York.
7. Boscaro, M., Sonino, N., Scarda, A., Barzon, L., Fallo, F., Sartori, M.T., Patrassi, G.M. & Girolami, A. (2002) Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 3662-3666.
8. Chalmers, J. (1999) WHO-ISH Hypertension Guidelines Committee 1999. World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Journal of Hypertension, 17, 151-185.
9. Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M. & Lombardi, G. (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism, 84, 2664-2672.
10. Danese, R.D. & Aron, D.C. (1994) Cushing's syndrome and hypertension. Endocrinology and Metabolism Clinics of North America, 23, 299-223.
11. Devereux, R.B., Alonso, D.R., Lutas, E.M., Gottlieb, G.J., Campo, E., Sachs, I. & Reichek, N. (1986) Echocardiographic assessment on left ventricular hypertrophy: comparison to necropsy findings. American Journal of Cardiology, 57, 450-458.
12. Emoto, M., Nishizawam, Y., Maekawam, K., Hiuram, Y., Kandam, H., Kawagishi, T., Shoji, T., Okuno, Y. & Morii, H. (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care, 22, 818-822.
13. Etxabe, J. & Vazquez, J.A. (1994) Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology, 23, 479-448.
14. Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M.C., Filippella, M., Di Somma, C., Lombardi, G. & Colao, A. (2003) Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. Journal of Clinical Endocrinology and Metabolism, 88, 2527-2533.
15. Fraser, R., Ingram, M.C., Anderson, N.H., Morrison, C., Davies, E. & Connell, J.M.C. (1999) Cortisol effects on body mass, blood pressure and cholesterol in the general population. Hypertension, 33, 1364-1368.
16. Friedman, T.C., Mastorakos, G., Newman, T.D., Mullen, N.M., Horton, E.G., Costello, R., Papadopoulos, N.M. & Chrousos, G.P. (1996) Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocrine Journal, 43, 645-655.
17. Garrapa, G.M., Pantanetti, P., Arnaldi, G., Mantero, F. & Faloia, E. (2001) Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 5301-5306.
18. Giraldi, F.P., Moro, M. & Cavagnini, F. (2003) Study group on the hypothalamo-pituitary-adrenal axis of the Italian Society of Endocrinology. Gender-related differences in the presentation and course of Cushing's disease. Journal of Clinical Endocrinology and Metabolism, 88, 1554-1558.
19. Kannel, W.B., Castelli, W.P., McNamara, P.M., McKee, PA. & Feinleib, M. (1972) Role of blood pressure in the development of congestive heart failure. The Framingham study. New England Journal of Medicine, 287, 781-787.
20. Laragh, J.H. & Brenner, B.M. (1995) Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn, p. 1987. Raven Press, New York.
21. Lindholm, J., Juul, S., Jorgensen, J.O., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jorgensen, J., Kosteljanetz, M., Kristensen, L., Laurberg, P., Schmidt, K. & Weeke, J. (2001) Incidence and late prognosis of Cushing's syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism, 86, 117-123.
22. MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., Abbott, R., Godwin, J., Dyer, A. & Stamler, J. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, 335, 765-774.
23. Mancini, T., Kola, B., Concettoni, C., Boscaro, M., Mantero, F. & Arnaldi, G. (2003) Hypertension in patients with Cushing's syndrome: evidence for gender difference in 11 βhydroxysteroid dehydrogenase type 2 activity. Abstract of the Endocrine Society 85th Annual Meeting, ENDO 2003, Philadelphia, June 19-22, 2003; Abstract P2-606, p. 454.
24. Mantero, F. & Boscaro, M. (1992) Glucocorticoid-dependent hypertension. Journal of Steroid Biochemistry and Molecular Biology, 43, 409-413.
25. Mantero, F., Armanini, D., Boscaro, M., Carpenè, G., Fallo, F., Opocher, G., Rocco, S., Scaroni, C. & Sonino, N. (1991) Steroid and hypertension. Journal of Steroid Biochemistry and Molecular Biology, 40, 35-44.
26. Matsuda, M. & DeFronzo, R.A. (1999) Insulin sensitivity indexes obtained from oral glucose tolerance testing. Comparing with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
27. Melanson, K.J., McInnis, K.J., Rippe, J.M., Blackburn, G. & Wilson, P.F. (2001) Obesity and cardiovascular disease risk: research update. Cardiology Review, 9, 202-207.
28. Muiesan, M.L., Lupia, M., Salvetti, M., Grigoletto, C., Sonino, N., Boscaro, M., Rosei, E.A., Mantero, F. & Fallo, F. (2003) Left ventricular structural and functional characteristics in Cushing's syndrome. Journal of the American College of Cardiology, 41, 2275-2279.
29. Palermo, M., Shackleton, C.H., Mantero, F. & Stewart, P.M. (1996) Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology, 45, 605-611.
30. Prospective studies collaboration. (1995) Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet, 346, 1647-1653.
31. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997) Guidelines. Diabetes Care, 20, 1183.
32. Reynolds, R.M., Walker, B.R., Syddall, H.E., Andrew, R., Wood, P.J., Whorwood, C.B. & Phillips, D.I.W (2001) Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factors. Journal of Clinical Endocrinology and Metabolism, 86, 245-250.
33. Rimm, E.B., Stampfer, M.J., Giovannucci, E., Ascherio, A., Spiegelman, D., Colditz, G.A. & Willett, W. (1995) Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. American Journal of Epidemiology, 141, 1117-1127.
34. Rosmond, R. & Björntorp, P. (2000) The hypothalamic-pituitary- adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. Journal of Internal Medicine, 247, 188-197.
35. Santos-Montes, A., Gonzalo-Lumbreras, R. & Izquierdo-Horaillos, R. (1995) Simultaneous determination of cortisol and cortisone in urine by reversed-phase high-performance liquid chromatography. Clinic and doping control application. Journal of Chromatography, 673, 27-33.
36. Terzolo, M., Pia, A., Ali, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G. & Angeli, A. (2002) Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism, 87, 998-1003.
37. Wagner, J.D., Kaplan, J.R. & Burkman, R.T. (2002) Reproductive hormones and cardiovascular disease mechanism of action and clinical implications. Obstetric and Gynecology Clinics of North America, 29, 475-493.
38. Walker, B.R., Soderberg, S., Lindahl, B. & Olsson, T. (2000) Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. Journal of Internal Medicine, 247, 198-204.
39. Walker, B.R., Souverein, P.C., Wei, L., Berard, A., Egberts, T.C.G., Leufkens, H.G.M., Cooper, C., van Staa, T. & MacDonald, T.M. (2003) Glucocorticoid therapy increases event rates from cardiovascular disease; results from two pharmacoepidemiological studies of 265 445 participants. Abstract of the Endocrine Society 85th Annual Meeting, ENDO 2003, Philadelphia, June 19-22, 2003; Abstract OR-30.2, p. 101.